Efficacy and safety of glycyrrhizin 2.5% eye drops in the treatment of moderate dry eye disease: results from a prospective, open-label pilot study.

Burillon C, Chiambaretta F, Pisella PJ

Open source

DOI
10.2147/opth.s186074
Published
2018
Container
Clinical ophthalmology (Auckland, N.Z.)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/opth.s186074,
  title = {Efficacy and safety of glycyrrhizin 2.5\% eye drops in the treatment of moderate dry eye disease: results from a prospective, open-label pilot study.},
  author = {Burillon C and Chiambaretta F and Pisella PJ},
  year = {2018},
  journal = {Clinical ophthalmology (Auckland, N.Z.)},
  doi = {10.2147/opth.s186074},
  url = {https://doi.org/10.2147/opth.s186074}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of glycyrrhizin 2.5% eye drops in the treatment of moderate dry eye disease: results from a prospective, open-label pilot study.
AU  - Burillon C
AU  - Chiambaretta F
AU  - Pisella PJ
PY  - 2018
JO  - Clinical ophthalmology (Auckland, N.Z.)
DO  - 10.2147/opth.s186074
UR  - https://doi.org/10.2147/opth.s186074
ER  - 

APA

C, B., F, C., & PJ, P. (2018). Efficacy and safety of glycyrrhizin 2.5% eye drops in the treatment of moderate dry eye disease: results from a prospective, open-label pilot study.. Clinical ophthalmology (Auckland, N.Z.). https://doi.org/10.2147/opth.s186074

Source records